These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12022363)

  • 1. Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats.
    Bauss F; Wagner M; Hothorn LH
    J Rheumatol; 2002 May; 29(5):990-8. PubMed ID: 12022363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.
    Bauss F; Lalla S; Endele R; Hothorn LA
    J Rheumatol; 2002 Oct; 29(10):2200-8. PubMed ID: 12375334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey.
    Müller R; Hannan M; Smith SY; Bauss F
    J Bone Miner Res; 2004 Nov; 19(11):1787-96. PubMed ID: 15476578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.
    Bauss F; Russell RG
    Osteoporos Int; 2004 Jun; 15(6):423-33. PubMed ID: 15205712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
    Kurth AH; Eberhardt C; Müller S; Steinacker M; Schwarz M; Bauss F
    Bone; 2005 Aug; 37(2):204-10. PubMed ID: 15936997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys.
    Smith SY; Recker RR; Hannan M; Müller R; Bauss F
    Bone; 2003 Jan; 32(1):45-55. PubMed ID: 12584035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibandronate: pharmacology and preclinical studies.
    Russell RG
    Bone; 2006 Apr; 38(4 Suppl 1):S7-12. PubMed ID: 16531132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of D-003, a mixture of high molecular weight aliphatic acids from sugar cane wax, on bones from ovariectomized rats.
    Noa M; Más R; Mendoza S; Gámez R; Mendoza N
    Drugs Exp Clin Res; 2004; 30(1):35-41. PubMed ID: 15134389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
    Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
    J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats.
    Ederveen AG; Spanjers CP; Quaijtaal JH; Kloosterboer HJ
    J Bone Miner Res; 2001 Sep; 16(9):1674-81. PubMed ID: 11547837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
    Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
    Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M; Zeng GQ; Turner CH
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
    Motoie H; Nakamura T; O'uchi N; Nishikawa H; Kanoh H; Abe T; Kawashima H
    J Bone Miner Res; 1995 Jun; 10(6):910-20. PubMed ID: 7572315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
    Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.